

Immunohistochemistry ( IHC ) Testing Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
The Immunohistochemistry (IHC) testing market is experiencing significant growth, driven by rising cancer incidence and increased research funding. The market size is projected to reach approximately $3.5 billion by 2025, reflecting a CAGR of around 6%. Technological advancements and growing clinical applications are enhancing market expansion and competitiveness.
Request Sample Report
◍ University of Texas MD Anderson Cancer Center
◍ Northwestern Memorial Hospital
◍ Johns Hopkins Hospital
◍ Memorial Sloan Kettering Cancer Center
◍ Cedars-Sinai Medical Center
◍ Mayo Clinic
◍ University of California San Francisco Medical Center
The Immunohistochemistry (IHC) Testing Market features major players like hospitals and cancer centers utilizing IHC for diagnostics and research. Institutions like MD Anderson and Mayo Clinic enhance market growth through advanced testing techniques, clinical trials, and collaborations that drive innovation. Sales revenues vary, with notable figures reaching millions in oncology services.
◍ Dana-Farber/Brigham and Women`s Cancer Center
◍ Cleveland Clinic
◍ Seattle Cancer Care Alliance/University of Washington Medical Center
◍ CancerResearchUK
◍ Pfizer
Hospital
Research Institute
Corporation
Other
◍ Traditional Direct Method ◍ New Direct Method ◍ Enzyme Bridgemethod
PAP Method
Request Sample Report
Request Sample Report
$ X Billion USD